70
Participants
Start Date
March 7, 2023
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2026
Testosterone treatment
Cross-sex hormone therapy consisting of intramuscular injection of testosterone undecanoate 250mg/ml. 4ml (total dosage of 1000mg) administered by trained nurse in the gluteal region at visit 1.
Placebo treatment
Saline solution. Intramuscular injection of physiological saline solution. 4ml administered by trained nurse in the gluteal region at visit 1.
RECRUITING
Karolinska Universitetssjukhuset, ANOVA, Stockholm
Karolinska University Hospital
OTHER